John Ding MD PhD
@IBD_JohnD
Associate Professor, Gastroenterologist - IBD, microbiome, Co-founder http://Medcompanion.com.au (digital tool - management of IBD and bowel preparation)
Starting 5 years ago with my first research student, I'm so glad they took a leap of faith in me. Our small research group consists of fantastic, brilliant people. I reflect on how fortunate I am to have met each of them and that they have contributed to my research and IBD
Another passion of mine is supporting bowel cancer research and raising awareness of bowel cancer! Particularly early onset bowel cancer which sadly Australia has the highest rates in the world. Thanks @BowelCancerAust
ONE DAY TO GO: Please join passionate Bowel Cancer Australia spokesperson Dr John Ding, in helping us to raise $200,000 tomorrow, to support the best and brightest scientists and clinicians dedicated to researching bowel cancer in younger people. June 18 is Red Apple Day, our…
ONE DAY TO GO: Please join passionate Bowel Cancer Australia spokesperson Dr John Ding, in helping us to raise $200,000 tomorrow, to support the best and brightest scientists dedicated to researching bowel cancer in younger people. June 19 is Red Apple Day, our Annual Giving…
What happens to our patients after faecal diversion with Crohn’s disease Check out our latest paper here: onlinelibrary.wiley.com/doi/10.1111/17… Thanks to co-authors @IBD_JohnD #imogenhartley
Thank you @RichardMarlesMP for meeting with us this week, as Jess and Kate shared their empowering lived experiences and we advocated for important policy change in relation to early-onset #BowelCancer for Bowel Cancer Australia’s #CallOnCanberra2024. #BowelCancerAustralia…
Thank you @MiltonDickMP for meeting with Peter, @IBD_JohnD (Bowel Cancer Australia spokesperson) and @steffbbrown (Bowel Cancer Australia) yesterday, as Peter and Steff shared their empowering stories and we advocated for important policy change in relation to early-onset…
🌸 Today, we celebrate the strength, resilience, and achievements of women everywhere! 💜✨ Let’s continue to uplift, empower, and support one another. #InternationalWomensDay
Age should not be a barrier for a #bowelcancer diagnosis!@BowelCancerAust continuing to raise awareness of #earlyonsetbowelcancer. Know your body. Act on symptoms and never be told your #tooyoung. 🙏@SarahNavin
Bowel cancer diagnoses in young Australians are on the rise, with the risk of being diagnosed before the age of 40 more than doubling since 2000. For those aged 15 to 24, rates have skyrocketed by 266 per cent over the past three decades. Julien Wiggins, CEO of Bowel Cancer…
Happy to share our study! After 4 weeks in active Crohn's - emulisifers within healthy diet have no impact on intestinal inflammation - a healthy diet ⬇️ sonographic inflammation, ⬇️fatigue, ⬆️quality of life, ⬆️clinical remission & improves body comp. @EmmaHalmos @MonashSTM
"Clinical Trial: The Effects of Emulsifiers in the Food Supply on Disease Activity in Crohn's Disease: An Exploratory Double-Blinded Randomised Feeding Trial" available open access via bit.ly/3XvNkon #GItwitter #Crohnsdisease #RCT #IBD
You are into #IBD, not at the #ECCO congress and have FOMO? 🤔 Well, you may be right...😉😉 @Y_ECCO_IBD @ibdseb @IBD_FloMD @DignassAxel @I_Blumenstein @Iagorlago @RestelliniS @DCharabaty @Bealoquebea @FernandoMagro6 @alearmuzzi @ICleynen @ign76 @IBD_JohnD @fgomollon
Free access to the ECCO'25 Abstract book: 👇👇🏽👇🏿 ecco-ibd.eu/publications/c… @IBD_FloMD @fgomollon @Y_ECCO_IBD @Bealoquebea @alearmuzzi @fgomollon @anaguticasbas @ibdseb @AlaaEl_Hussuna @IBD_MB @RPanaccione @DignassAxel @I_Blumenstein @GianlucaPellino @bverstockt @DCharabaty
Our article on protocolising care through medical and surgical treatment for fistulising Crohn's disease demonstrates that targeting different stages of disease is important➡️⬆️radiologic healing in 25%. Thanks to patients and our team. academic.oup.com/ecco-jcc/advan… @ANZIBDC
🌏 Survey of Asia-Pacific clinicians reveals consensus on H. pylori management to curb gastric cancer ✔️ 1st-line: CAM triple therapy ✔️ 2nd-line: LVX triple therapy ✔️ 81.6% support eradication in asymptomatic adults 🔗 onlinelibrary.wiley.com/doi/10.1111/jg…
Great to meet old and new friends face-to-face at @apdw2024bali #apdw2024bali
Withdrawal of IFX in pts with steroid free remission in Crohn's. - about 1/3 will have a relapse by 2 years - factors: <17yo at dx, active smoking, presence of stricture, ↑ CRP, ↑ calprotectin, ↑ CDEIS - retreatment with IFX is successful is almost all patients (22 of 23 pts)
Harms in IBD RCTs. Please read our induction and maintenance studies here with thx @alex_ford12399 @ShahidaDin1 @Bealoquebea @JonnyBlackwell @DrCJBlack thelancet.com/journals/langa… thelancet.com/journals/langa…
We are pleased to share the clinical results of the PREDICT-UC study investigating infliximab dose strategies in ASUC. Thank you to @LancetGastroHep for sharing our research. The full paper can be freely accessed via this link sciencedirect.com/science/articl… @DrChrisLi @Austin_Health
Histology in ulcerative colitis - architectural distortion (chronicity) - basal lymphoplasmacytosis (chronicity) - neutrophilic infiltration (activity) Nancy index for grading histologic activity
As the medical spokesperson for @BowelCancerAust this is very exciting news and hopefully more Australians will take this opportunity to get screened!
Australians aged 45-49 can now opt-in to the National Bowel Cancer Screening Program (NBCSP). For further details and to opt-in click here bit.ly/bowelcanceraus… Since 2018, Bowel Cancer Australia has advocated for screening from age 45 given the rising rate of bowel cancer in…
It was an honour as the medical spokesperson for @BowelCancerAust to meet with our Deputy Prime Minister to further the cause of early onset bowel cancer. Thanks @BowelCancerAust
Thank you @RichardMarlesMP for meeting with us this week, as Jess and Kate shared their empowering lived experiences and we advocated for important policy change in relation to early-onset #BowelCancer for Bowel Cancer Australia’s #CallOnCanberra2024. #BowelCancerAustralia…
New ECCO CD guidelines. Hugely proud to have led with @HannahGordon @PMyrelid @MichelAdaminamassive team effort from >50 clinicians, patients & methodologists representing 19 countries& 4 continents. A thread on what we did &why it does (&doesn’t) matter. doi.org/10.1093/ecco-j…
'To allow a whole new cadre of young leaders to be identified more efficiently, so that our twin specialties of gastroenterology and hepatology remain in good hands, and that our contributions to health grow' 🌱🌏 - Prof. Farrell & Neomans #ELC #APAGE 🔗 onlinelibrary.wiley.com/doi/full/10.11…